Clinical Trials in Northbrook, Illinois
9 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche152 enrolled82 locationsNCT05271409
Recruiting
Phase 3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Sanofi1,600 enrolled384 locationsNCT06141473
Recruiting
Not Applicable
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
pelvic organ prolapseProlapse
Medstar Health Research Institute218 enrolled9 locationsNCT06634459
Recruiting
Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
Breast Reconstruction
AbbVie783 enrolled21 locationsNCT06575192
Recruiting
Phase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
Sanofi900 enrolled338 locationsNCT06141486
Recruiting
Phase 2
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Chronic Spontaneous UrticariaChronic Inducible Urticaria
Blueprint Medicines Corporation105 enrolled47 locationsNCT06931405
Recruiting
Phase 2
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
Parkinson's Disease (PD)
TrueBinding, Inc.62 enrolled14 locationsNCT06773962
Recruiting
Phase 2
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Multiple Sclerosis
Eli Lilly and Company200 enrolled50 locationsNCT06220669
Recruiting
Phase 3
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Vision Loss NightVision Disorders
Ocuphire Pharma, Inc.200 enrolled23 locationsNCT07140783